ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 29

$910K Total Retail Price of All Prescriptions

Rank: 4 out of 29

587 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 20,185 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 904 904 1 2
HYDROCODONE-ACETAMINOPHEN 875 874 S3 2 7
AMLODIPINE BESYLATE 701 700 3 5
SIMVASTATIN 648 636 4 4
LEVOTHYROXINE SODIUM 612 612 5 1
FUROSEMIDE 596 584 6 3
METOPROLOL TARTRATE 585 585 7 15
POTASSIUM CHLORIDE 536 524 8 6
GABAPENTIN 490 465 9 10
DONEPEZIL HCL 474 474 10 9
TRAZODONE HCL 438 426 11 22
OMEPRAZOLE 432 431 12 8
HYDROCHLOROTHIAZIDE 384 384 13 20
METOPROLOL SUCCINATE 371 371 14 16
NAMENDA 369 369 15 12
SERTRALINE HCL 354 345 16 17
TRAMADOL HCL 302 302 17 24
CITALOPRAM HBR 284 284 18 11
MIRTAZAPINE 262 262 19 13
WARFARIN SODIUM 248 226 20 14
LOSARTAN POTASSIUM 238 238 21 28
DIOVAN 233 233 22 35
MELOXICAM 215 215 23 36
ZOLPIDEM TARTRATE 211 211 24 30
ALENDRONATE SODIUM 200 200 25 26
ATENOLOL 185 185 26 23
NORTRIPTYLINE HCL 182 182 27 73
NEXIUM 180 180 28 47
PAROXETINE HCL 174 174 29 68
SYNTHROID 158 158 30 52
CLOPIDOGREL 148 148 31 33
QUETIAPINE FUMARATE 141 141 32 32
ATORVASTATIN CALCIUM 137 137 33 25
EVISTA 133 133 34 55
ESCITALOPRAM OXALATE 127 127 35 37
DIGOXIN 126 126 36 34
ISOSORBIDE MONONITRATE ER 121 121 37 44
NIFEDIPINE ER 115 115 38 95
PREDNISONE 114 101 39 41
CARBIDOPA-LEVODOPA 111 111 40 42
HYDRALAZINE HCL 104 104 41 56
PRAVASTATIN SODIUM 100 100 42 18
GLIPIZIDE 99 99 43 50
CLONIDINE HCL 98 98 44 53
LYRICA 97 97 45 67
PLAVIX 97 97 45 51
ALLOPURINOL 96 96 47 40
PROAIR HFA 94 94 48 160
ENALAPRIL MALEATE 93 93 49 72
OXYCODONE HCL 88 87 S2 50 78
ZETIA 88 88 50 125
OXYCODONE-ACETAMINOPHEN 86 86 S2 52 131
CIPROFLOXACIN HCL 86 86 52 66
RISPERIDONE 86 86 52 49
TRIAMTERENE-HCTZ 84 84 55 48
CARVEDILOL 77 77 56 27
CARBAMAZEPINE 76 76 57 145
TAMSULOSIN HCL 73 73 58 31
METFORMIN HCL 73 73 58 19
POLYETHYLENE GLYCOL 3350 72 72 60 46
PROPRANOLOL HCL 71 71 61 70
FLUTICASONE PROPIONATE 70 70 62 43
CALCITONIN-SALMON 69 69 63 135
SPIRONOLACTONE 68 68 64 54
FENTANYL 66 66 S2 65 76
CEPHALEXIN 64 64 66 89
METHOCARBAMOL 62 62 R 67 187
AZITHROMYCIN 61 61 68 62
SEROQUEL 61 61 68 71
ADVAIR DISKUS 59 59 70 68
MORPHINE SULFATE ER 58 39 S2 71 148
AMOX TR-POTASSIUM CLAVULANATE 57 57 72 100
VENLAFAXINE HCL ER 57 57 72 87
FINASTERIDE 55 55 74 111
VENLAFAXINE HCL 55 43 74 93
FAMOTIDINE 55 55 74 61
SYMBICORT 53 50 77 155
CELEBREX 53 53 77 106
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 79 119
DILTIAZEM HCL 52 52 79 115
LEXAPRO 52 52 79 151
PANTOPRAZOLE SODIUM 50 50 82 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.